A Snapshot on the On-Label and Off-Label Use of the Interleukin-1 Inhibitors in Italy among Rheumatologists and Pediatric Rheumatologists: A Nationwide Multi-Center Retrospective Observational StudyAntonio Vitale, Luca Cantarini, Marta Mosca et al.|Frontiers in Pharmacology|2016Cited by 88
Safety profile of the interleukin-1 inhibitors anakinra and canakinumab in real-life clinical practice: a nationwide multicenter retrospective observational studyMario Messina, Romina Gallizzi, Chiara Stagnaro et al.|Clinical Rheumatology|2018Cited by 82
Anakinra Drug Retention Rate and Predictive Factors of Long-Term Response in Systemic Juvenile Idiopathic Arthritis and Adult Onset Still DiseaseJurgen Sota, Luca Cantarini, Romina Gallizzi et al.|Frontiers in Pharmacology|2019Cited by 45